Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell of lymphatic vessel | 8 studies | 26% ± 9% | |
| classical monocyte | 4 studies | 23% ± 7% | |
| non-classical monocyte | 3 studies | 28% ± 4% | |
| endothelial cell | 3 studies | 26% ± 6% | |
| goblet cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of SLC27A3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 2180.97 | 180 / 180 | 100% | 21.48 | 430 / 430 |
| uterus | 100% | 2393.09 | 170 / 170 | 99% | 23.81 | 455 / 459 |
| thymus | 100% | 2270.73 | 653 / 653 | 99% | 12.71 | 599 / 605 |
| lung | 100% | 4315.35 | 576 / 578 | 99% | 18.27 | 1147 / 1155 |
| breast | 100% | 3906.29 | 459 / 459 | 98% | 19.65 | 1093 / 1118 |
| esophagus | 100% | 1964.14 | 1441 / 1445 | 98% | 13.73 | 179 / 183 |
| liver | 99% | 1822.07 | 223 / 226 | 99% | 37.05 | 401 / 406 |
| intestine | 100% | 2146.09 | 966 / 966 | 97% | 13.59 | 513 / 527 |
| bladder | 100% | 2442.05 | 21 / 21 | 97% | 18.52 | 489 / 504 |
| stomach | 99% | 2974.43 | 355 / 359 | 98% | 13.19 | 279 / 286 |
| prostate | 100% | 1875.16 | 245 / 245 | 96% | 11.00 | 483 / 502 |
| kidney | 100% | 1891.90 | 89 / 89 | 91% | 20.08 | 824 / 901 |
| pancreas | 92% | 795.06 | 301 / 328 | 99% | 19.17 | 177 / 178 |
| skin | 94% | 2036.60 | 1696 / 1809 | 95% | 69.91 | 448 / 472 |
| adrenal gland | 95% | 947.55 | 244 / 258 | 86% | 12.34 | 198 / 230 |
| brain | 72% | 805.13 | 1915 / 2642 | 84% | 12.93 | 592 / 705 |
| adipose | 100% | 4091.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 11.72 | 29 / 29 |
| spleen | 100% | 1929.44 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 17.79 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.05 | 1 / 1 |
| blood vessel | 100% | 3679.20 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 93% | 10.83 | 74 / 80 |
| heart | 91% | 945.90 | 787 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 89% | 1062.32 | 827 / 929 | 0% | 0 | 0 / 0 |
| muscle | 30% | 202.12 | 243 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0015908 | Biological process | fatty acid transport |
| GO_0001676 | Biological process | long-chain fatty acid metabolic process |
| GO_0031966 | Cellular component | mitochondrial membrane |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0016020 | Cellular component | membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0004467 | Molecular function | long-chain fatty acid-CoA ligase activity |
| GO_0047676 | Molecular function | arachidonate-CoA ligase activity |
| GO_0031957 | Molecular function | very long-chain fatty acid-CoA ligase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | SLC27A3 |
| Protein name | Long-chain fatty acid transport protein 3 (FATP-3) (Fatty acid transport protein 3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 3) (Very long-chain acyl-CoA synthetase homolog 3) (VLCS-3) (EC 6.2.1.-) long-chain-fatty-acid--CoA ligase (EC 6.2.1.3) (Long-chain-fatty-acid--CoA ligase) long-chain-fatty-acid--CoA ligase (EC 6.2.1.3) Long-chain fatty acid transport protein 3 (Solute carrier family 27 member 3) |
| Synonyms | UNQ367/PRO703 ACSVL3 PSEC0067 hCG_19279 FATP3 |
| Description | FUNCTION: Mainly functions as an acyl-CoA ligase catalyzing the ATP-dependent formation of fatty acyl-CoA using LCFA and very-long-chain fatty acids (VLCFA) as substrates . Can mediate the levels of long-chain fatty acids (LCFA) in the cell by facilitating their transport across membranes (By similarity). . |
| Accessions | Q5K4L6 ENST00000458027.5 H0YDM5 ENST00000532853.5 ENST00000575532.1 ENST00000271857.6 ENST00000575439.5 X6R3N0 ENST00000573411.5 ENST00000623839.3 H7BZH4 ENST00000570870.5 ENST00000524676.1 H0YDP0 ENST00000624995.4 [Q5K4L6-1] |